10-Q 1 smg-330201910xq2.htm 10-Q Document

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_________________________________________
FORM 10-Q
_________________________________
(Mark One)
ý
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 30, 2019
OR
o 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from
 
to
     
Commission File Number: 001-11593
____________________________________ 
The Scotts Miracle-Gro Company
(Exact name of registrant as specified in its charter)
______________________________________________
OHIO
 
31-1414921
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)
 
 
14111 SCOTTSLAWN ROAD,
MARYSVILLE, OHIO
 
43041
(Address of principal executive offices)
 
(Zip Code)
(937) 644-0011
(Registrant’s telephone number, including area code)
______________________________________________ 
(Former name, former address and former fiscal year, if changed since last report)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ý    No  o 
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ý    No  o 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
 
ý
  
Accelerated filer
 
o 
Non-accelerated filer
 
o 
  
Smaller reporting company
 
o 
Emerging growth company
 
o 
 
 
 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o  
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  o     No  ý
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
 
Trading Symbol(s)
 
Name of each exchange on which registered
Common Shares, $0.01 stated value
 
SMG
 
NYSE
As of May 3, 2019, there were 55,471,465 Common Shares outstanding.


1



THE SCOTTS MIRACLE-GRO COMPANY
INDEX

 
 
 
 
 
PAGE NO.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Item 3.
Item 4.
Item 5.

2


PART I—FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS

THE SCOTTS MIRACLE-GRO COMPANY
Condensed Consolidated Statements of Operations
(In millions, except per share data)
(Unaudited)
 
 
THREE MONTHS ENDED
 
SIX MONTHS ENDED
 
MARCH 30,
2019
 
MARCH 31,
2018
 
MARCH 30,
2019
 
MARCH 31,
2018
Net sales
$
1,189.9

 
$
1,013.3

 
$
1,488.0

 
$
1,234.9

Cost of sales
716.8

 
604.1

 
977.8

 
791.7

Cost of sales—impairment, restructuring and other
1.0

 

 
3.5

 

Gross profit
472.1

 
409.2

 
506.7

 
443.2

Operating expenses:
 
 
 
 
 
 
 
Selling, general and administrative
179.7

 
166.0

 
296.0

 
274.2

Impairment, restructuring and other
0.2

 
10.2

 
3.7

 
10.0

Other (income) expense, net
2.0

 
0.7

 
1.6

 
(1.4
)
Income from operations
290.2

 
232.3

 
205.4

 
160.4

Equity in income of unconsolidated affiliates
(2.0
)
 
(1.5
)
 
(3.3
)
 
(2.1
)
Interest expense
28.9

 
22.6

 
54.1

 
40.4

Other non-operating (income) expense, net
(260.1
)
 
9.2

 
(262.9
)
 
6.7

Income from continuing operations before income taxes
523.4

 
202.0

 
417.5

 
115.4

Income tax expense (benefit) from continuing operations
126.5

 
49.3

 
103.2

 
(17.3
)
Income from continuing operations
396.9

 
152.7

 
314.3

 
132.7

Income (loss) from discontinued operations, net of tax
(0.5
)
 
(3.7
)
 
2.5

 
(4.9
)
Net income
$
396.4

 
$
149.0

 
$
316.8

 
$
127.8

Net (income) loss attributable to noncontrolling interest
0.1

 
(0.1
)
 
0.1

 
(0.1
)
Net income attributable to controlling interest
$
396.5

 
$
148.9

 
$
316.9

 
$
127.7

 
 
 
 
 
 
 
 
Basic income (loss) per common share:
 
 
 
 
 
 
 
Income from continuing operations
$
7.17

 
$
2.70

 
$
5.68

 
$
2.33

Income (loss) from discontinued operations
(0.01
)
 
(0.06
)
 
0.04

 
(0.09
)
Basic income per common share
$
7.16

 
$
2.64

 
$
5.72

 
$
2.24

Weighted-average common shares outstanding during the period
55.4

 
56.5

 
55.4

 
57.0

 
 
 
 
 
 
 
 
Diluted income (loss) per common share:
 
 
 
 
 
 
 
Income from continuing operations
$
7.10

 
$
2.66

 
$
5.62

 
$
2.29

Income (loss) from discontinued operations
(0.01
)
 
(0.07
)
 
0.05

 
(0.09
)
Diluted income per common share
$
7.09

 
$
2.59

 
$
5.67

 
$
2.20

Weighted-average common shares outstanding during the period plus dilutive potential common shares
55.9

 
57.4

 
55.9

 
58.0

See Notes to Condensed Consolidated Financial Statements.

3


THE SCOTTS MIRACLE-GRO COMPANY
Condensed Consolidated Statements of Comprehensive Income (Loss)
(In millions)
(Unaudited)

 
THREE MONTHS ENDED
 
SIX MONTHS ENDED
 
MARCH 30,
2019
 
MARCH 31,
2018
 
MARCH 30,
2019
 
MARCH 31,
2018
Net income
$
396.4

 
$
149.0

 
$
316.8

 
$
127.8

Other comprehensive income (loss):
 
 
 
 
 
 
 
Net foreign currency translation adjustment, including reclassifications to net income of $2.5, $11.7, $2.5 and $11.7, respectively
0.7

 
15.8

 
(4.6
)
 
15.7

Net unrealized gain (loss) on derivative instruments, net of tax of $(0.8), $0.8, $(3.6) and $1.1, respectively
(2.4
)
 
2.0

 
(10.3
)
 
2.8

Reclassification of net unrealized gains on derivative instruments to net income, net of tax of $(0.7), $(0.4), $(0.7) and $(0.5), respectively
(1.9
)
 
(1.1
)
 
(2.0
)
 
(1.2
)
Reclassification of net pension and other post-retirement benefit (gains) losses to net income, net of tax of $(0.1), $0.1, $0.2 and $0.2, respectively
(0.3
)
 
0.3

 
0.6

 
0.6

Total other comprehensive income (loss)
(3.9
)
 
17.0

 
(16.3
)
 
17.9

Comprehensive income
392.5

 
166.0

 
300.5

 
145.7

Comprehensive (income) loss attributable to noncontrolling interest
0.1

 
(0.1
)
 
0.1

 
(0.1
)
Comprehensive income attributable to controlling interest
$
392.6

 
$
165.9

 
$
300.6

 
$
145.6

See Notes to Condensed Consolidated Financial Statements.


4


THE SCOTTS MIRACLE-GRO COMPANY
Condensed Consolidated Statements of Cash Flows
(In millions)
(Unaudited)
 
SIX MONTHS ENDED
 
MARCH 30,
2019
 
MARCH 31,
2018
OPERATING ACTIVITIES
 
 
 
Net income
$
316.8

 
$
127.8

Adjustments to reconcile net income to net cash used in operating activities:
 
 
 
Impairment, restructuring and other
0.5

 

Share-based compensation expense
17.0

 
15.7

Depreciation
27.9

 
25.5

Amortization
16.8

 
14.1

Deferred taxes
(37.5
)
 
(45.9
)
(Gain) loss on long-lived assets
0.9

 
(0.2
)
(Gain) loss on sale of business / unconsolidated affiliate
(259.8
)
 
3.5

Recognition of accumulated foreign currency translation loss
2.5

 
11.7

Equity in (income) loss and distributions from unconsolidated affiliates
1.6

 
(2.1
)
Changes in assets and liabilities, net of acquired businesses:
 
 
 
Accounts receivable
(723.9
)
 
(643.0
)
Inventories
(196.5
)
 
(184.1
)
Prepaid and other assets
(42.9
)
 
(9.1
)
Accounts payable
154.5

 
113.9

Other current liabilities
238.2

 
97.3

Restructuring and other
(55.9
)
 
5.2

Other non-current items
(7.0
)
 
(12.9
)
Other, net
0.7

 
(0.2
)
Net cash used in operating activities
(546.1
)
 
(482.8
)
 
 
 
 
INVESTING ACTIVITIES
 
 
 
Proceeds from sale of long-lived assets
0.1

 
0.2

Post-closing working capital payment related to sale of International Business

 
(35.3
)
Investments in property, plant and equipment
(20.9
)
 
(33.1
)
Proceeds from (investments in) loans receivable
18.4

 
(7.7
)
Proceeds from sale of investment in unconsolidated affiliates
237.7

 

Investments in acquired businesses, net of cash acquired
(6.6
)
 
(72.0
)
Other investing, net
1.0

 

Net cash provided by (used in) investing activities
229.7

 
(147.9
)
 
 
 
 
FINANCING ACTIVITIES
 
 
 
Borrowings under revolving and bank lines of credit and term loans
777.9

 
1,172.6

Repayments under revolving and bank lines of credit and term loans
(394.2
)
 
(243.4
)
Dividends paid
(61.6
)
 
(60.3
)
Purchase of Common Shares
(3.0
)
 
(256.8
)
Payments on seller notes
(0.8
)
 
(3.0
)
Cash received from exercise of stock options
2.3

 
3.8

Acquisition of noncontrolling interests

 
(72.2
)
Net cash provided by financing activities
320.6

 
540.7

Effect of exchange rate changes on cash
(0.6
)
 
2.5

Net increase (decrease) in cash and cash equivalents
3.6

 
(87.5
)
Cash and cash equivalents at beginning of period
33.9

 
120.5

Cash and cash equivalents at end of period
$
37.5

 
$
33.0

See Notes to Condensed Consolidated Financial Statements.

5


THE SCOTTS MIRACLE-GRO COMPANY
Condensed Consolidated Balance Sheets
(In millions, except stated value per share)
(Unaudited)
 
 
MARCH 30,
2019
 
MARCH 31,
2018
 
SEPTEMBER 30,
2018
ASSETS
Current assets:
 
 
 
 
 
Cash and cash equivalents
$
37.5

 
$
33.0

 
$
33.9

Accounts receivable, less allowances of $8.8, $6.9 and $3.6, respectively
699.6

 
598.0

 
226.0

Accounts receivable pledged
333.3

 
333.3

 
84.5

Inventories
675.3

 
596.9

 
481.4

Prepaid and other current assets
93.7

 
78.1

 
59.9

Total current assets
1,839.4

 
1,639.3

 
885.7

Investment in unconsolidated affiliates
34.5

 
33.2

 
36.1

Property, plant and equipment, net of accumulated depreciation of $636.4, $614.2 and $610.5, respectively
513.9

 
463.6

 
530.8

Goodwill
539.6

 
466.8

 
543.0

Intangible assets, net
837.9

 
777.6

 
857.3

Other assets
191.2

 
195.0

 
201.6

Total assets
$
3,956.5

 
$
3,575.5

 
$
3,054.5

 
 
 
 
 
 
LIABILITIES AND EQUITY
Current liabilities:
 
 
 
 
 
Current portion of debt
$
357.7

 
$
335.8

 
$
132.6

Accounts payable
298.7

 
253.5

 
150.5

Other current liabilities
503.5

 
316.8

 
329.6

Total current liabilities
1,159.9

 
906.1

 
612.7

Long-term debt
2,039.1

 
1,937.7

 
1,883.8

Distributions in excess of investment in unconsolidated affiliate

 
21.9

 
21.9

Other liabilities
135.4

 
213.9

 
176.5

Total liabilities
3,334.4

 
3,079.6

 
2,694.9

Commitments and contingencies (Note 12)

 

 

Equity:
 
 
 
 
 
Common shares and capital in excess of $.01 stated value per share; shares outstanding of 55.4, 55.6 and 55.3, respectively
426.2

 
409.0

 
420.3

Retained earnings
1,199.2

 
1,044.5

 
919.9

Treasury shares, at cost; 12.7, 12.5 and 12.8 shares, respectively
(929.0
)
 
(911.4
)
 
(939.6
)
Accumulated other comprehensive loss
(79.2
)
 
(51.3
)
 
(46.0
)
Total equity—controlling interest
617.2

 
490.8

 
354.6

Noncontrolling interest
4.9

 
5.1

 
5.0

Total equity
622.1

 
495.9

 
359.6

Total liabilities and equity
$
3,956.5

 
$
3,575.5

 
$
3,054.5

See Notes to Condensed Consolidated Financial Statements.

6


NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
NOTE 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Nature of Operations
The Scotts Miracle-Gro Company (“Scotts Miracle-Gro” or “Parent”) and its subsidiaries (collectively, together with Scotts Miracle-Gro, the “Company”) are engaged in the manufacturing, marketing and sale of products for lawn and garden care and indoor, urban and hydroponic gardening. The Company’s products are sold in North America, Europe and Asia.
Due to the seasonal nature of the consumer lawn and garden business, the majority of the Company’s sales to customers occur in the Company’s second and third fiscal quarters. On a combined basis, net sales for the second and third quarters of the last three fiscal years represented in excess of 75% of the Company’s annual net sales.
Organization and Basis of Presentation
The Company’s unaudited condensed consolidated financial statements for the three and six months ended March 30, 2019 and March 31, 2018 are presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The condensed consolidated financial statements include the accounts of Scotts Miracle-Gro and its subsidiaries. All intercompany transactions and accounts have been eliminated in consolidation. The Company’s consolidation criteria are based on majority ownership (as evidenced by a majority voting interest in the entity) and an objective evaluation and determination of effective management control. AeroGrow International, Inc. (“AeroGrow”), in which the Company has a controlling interest, is consolidated, with the equity owned by other shareholders shown as noncontrolling interest in the Condensed Consolidated Balance Sheets, and the other shareholders’ portion of net earnings and other comprehensive income shown as net (income) loss or comprehensive (income) loss attributable to noncontrolling interest in the Condensed Consolidated Statements of Operations and Condensed Consolidated Statements of Comprehensive Income (Loss), respectively. The results of businesses acquired or disposed of are included in the condensed consolidated financial statements from the date of each acquisition or up to the date of disposal, respectively. In the opinion of management, interim results reflect all normal and recurring adjustments and are not necessarily indicative of results for a full year.
Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been omitted or condensed pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Accordingly, this Quarterly Report on Form 10-Q should be read in conjunction with Scotts Miracle-Gro’s Annual Report on Form 10-K for the fiscal year ended September 30, 2018 (the “2018 Annual Report”), which includes a complete set of footnote disclosures, including the Company’s significant accounting policies.
The Company’s Condensed Consolidated Balance Sheet at September 30, 2018 has been derived from the Company’s audited Consolidated Balance Sheet at that date, but does not include all of the information and footnotes required by GAAP for complete financial statements.
Long-Lived Assets
The Company had non-cash investing activities of $3.6 million and $3.3 million during the six months ended March 30, 2019 and March 31, 2018, respectively, representing unpaid liabilities incurred during each period to acquire property, plant and equipment.
Statements of Cash Flows
Supplemental cash flow information was as follows:
 
SIX MONTHS ENDED
 
MARCH 30,
2019
 
MARCH 31,
2018
 
(In millions)
Interest paid
$
(49.8
)
 
$
(35.7
)
Income taxes paid
(7.5
)
 
(14.5
)

7


During the six months ended March 30, 2019, the Company paid a post-closing net working capital adjustment obligation of $6.6 million related to the acquisition of Sunlight Supply (as defined in “NOTE 4. ACQUISITIONS AND INVESTMENTS”) during the fiscal year ended September 30, 2018 (“fiscal 2018”), which was classified as an investing activity in the “Investments in acquired businesses, net of cash acquired” line in the Condensed Consolidated Statements of Cash Flows. During the six months ended March 31, 2018, the Company paid contingent consideration of $3.0 million related to the acquisition of Gavita Holdings B.V., and its subsidiaries (collectively, “Gavita”) during the fiscal year ended September 30, 2016 (“fiscal 2016”), which was classified as a financing activity in the “Payments on seller notes” line in the Condensed Consolidated Statements of Cash Flows.
RECENTLY ADOPTED ACCOUNTING PRONOUNCEMENTS
Revenue Recognition from Contracts with Customers
In May 2014, the Financial Accounting Standards Board (“FASB”) issued amended accounting guidance that replaces most existing revenue recognition guidance under GAAP. This guidance requires companies to recognize revenue in a manner that depicts the transfer of promised goods or services to customers in amounts that reflect the consideration to which a company expects to be entitled in exchange for those goods or services. The standard involves a five-step process that includes identifying the contract with the customer, identifying the performance obligations in the contract, determining the transaction price, allocating the transaction price to the performance obligations in the contract and recognizing revenue when the entity satisfies the performance obligations. The new standard also results in enhanced disclosures about the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. Subsequently, additional guidance was issued on several areas including guidance intended to improve the operability and understandability of the implementation of principal versus agent considerations and clarifications on the identification of performance obligations and implementation of guidance related to licensing.
The Company adopted this guidance effective October 1, 2018 under the modified retrospective approach. The Company’s revenue primarily consists of product sales, which are recognized at a point in time when title transfers to customers and the Company has no further obligation to provide services related to such products. The Company’s timing of recognition of revenue is substantially unchanged under the amended guidance. The new accounting guidance required the Company to recognize earlier certain deferred revenue associated with a license agreement related to the sale of the International Business (as defined in “NOTE 3. DISCONTINUED OPERATIONS”), resulting in a cumulative adjustment to its opening balance for the fiscal year ended September 30, 2019 (“fiscal 2019”) of retained earnings of $9.1 million, other current liabilities of $1.4 million and other liabilities of $7.7 million. With the exception of this item, the adoption of the amended accounting guidance did not have a material impact on the Company’s condensed consolidated financial statements. The additional disclosures required are presented within “NOTE 2. REVENUE RECOGNITION” and “NOTE 15. SEGMENT INFORMATION.”
Cash Flow Presentation
In August 2016, the FASB issued an accounting standard update that amends the guidance on the classification of certain cash receipts and payments in the statement of cash flows. The Company adopted this guidance on a retrospective basis effective October 1, 2018. The adoption of this guidance did not have a significant impact on the Company’s consolidated cash flows.
Business Combinations
In January 2017, the FASB issued an accounting standard update that clarifies the definition of a business to provide additional guidance to assist in evaluating whether transactions should be accounted for as an acquisition (or disposal) of either an asset or business. The Company adopted this guidance on a prospective basis effective October 1, 2018. The adoption of this guidance did not have a significant impact on the Company’s consolidated financial position, results of operations or cash flows.
Employee Benefit Plans
In March 2017, the FASB issued an accounting standard update that requires entities to (1) disaggregate the current-service-cost component from the other components of net benefit cost (the “other components”) and present the current-service-cost with other current compensation costs for related employees in the income statement, (2) present the other components elsewhere in the income statement and outside of income from operations if that subtotal is presented and (3) limit the amount of costs eligible for capitalization (e.g., as part of inventory or property, plant, and equipment) to only the service-cost component of net benefit cost. The provisions are required to be applied retrospectively for the presentation of cost components in the income statement and prospectively for the capitalization of cost components. The Company adopted this guidance effective October 1, 2018 and has classified non-service-cost components of net benefit cost/income in the “Other non-operating income, net” line in the Condensed Consolidated Statements of Operations. The adoption of this guidance did not have a significant impact on the Company’s consolidated financial position, results of operations or cash flows.

8


Income Taxes
On December 22, 2017, H.R.1 (the “Act,” formerly known as the “Tax Cuts and Jobs Act”) was signed into law. The Act provides for significant changes to the U.S. Internal Revenue Code of 1986, as amended (the “Code”). Among other items, the Act implemented a territorial tax system, imposed a one-time transition tax on deemed repatriated earnings of foreign subsidiaries, and reduced the federal corporate statutory tax rate to 21% effective January 1, 2018.
Additionally, the Securities and Exchange Commission (the “SEC”) released Staff Accounting Bulletin No. 118 (“SAB 118”) which provides guidance on accounting for the Act’s impact under Accounting Standards Codification (“ASC”) Topic 740, Income Taxes (“ASC 740”). The guidance in SAB 118 allowed companies to use provisional estimates to record the effects of the Act and also provided a measurement period (not to exceed one year from the date of enactment) to complete the accounting for the impacts of the Act. The Company completed its accounting for the impacts of the Act during the first quarter of fiscal 2019.
For discussion of the impacts of the Act that are material to the Company and required disclosures related to the Act pursuant to the guidance provided under SAB 118, refer to “NOTE 11. INCOME TAXES.”
Reporting Comprehensive Income
In February 2018, the FASB issued an accounting standard update that allows a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Act. The Company elected to adopt this guidance effective October 1, 2018, resulting in a reclassification of $16.9 million from accumulated other comprehensive income (loss) (“AOCI”) to retained earnings upon adoption.
Share-Based Compensation
In June 2018, the FASB issued an accounting standard update that simplifies the accounting for share-based payments granted to nonemployees for goods and services. Under the amended accounting guidance, most of the guidance on such payments to nonemployees would be aligned with the requirements for share-based payments granted to employees. The Company elected to adopt this guidance effective October 1, 2018. The adoption of this guidance did not have a significant impact on the Company’s consolidated financial position, results of operations or cash flows.
RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS
Leases
In February 2016, the FASB issued its final standard on lease accounting. This guidance requires lessees to recognize a lease liability for the obligation to make lease payments and a right-of-use asset for the right to use the underlying asset for the lease term. The provisions are effective for the Company’s financial statements no later than the fiscal year beginning October 1, 2019 and require a modified retrospective transition approach for leases that exist as of or are entered into after the beginning of either (i) the date of adoption or (ii) the earliest comparative period presented in the financial statements. The Company is currently evaluating available transition methods and the impact of this standard on its consolidated results of operations, financial position and cash flows. The Company has made progress on its evaluation of the amended guidance, including identification of the population of leases affected, determining the information required to calculate the lease liability and right-of-use asset and evaluating models to assist in future reporting.
Credit Losses
In June 2016, the FASB issued an accounting standard update related to the measurement of credit losses on financial instruments. The amended accounting guidance changes the impairment model for most financial assets to require measurement and recognition of expected credit losses for financial assets held.   The provisions are effective for the Company’s financial statements no later than the fiscal year beginning October 1, 2020.  The Company is continuing to assess the impact of the amended guidance.
Cloud Computing Costs
In August 2018, the FASB issued an accounting standard update that aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The provisions are effective for the Company’s financial statements no later than the fiscal year beginning October 1, 2020.  The Company is continuing to assess the impact of the amended guidance.
Employee Benefit Plans
In August 2018, the FASB issued an accounting standard update that removes certain disclosures that are not considered cost beneficial, clarifies certain required disclosures and requires certain additional disclosures. The provisions are effective for

9


the Company’s financial statements no later than the fiscal year beginning October 1, 2020.  The Company is continuing to assess the impact of the amended guidance.
NOTE 2. REVENUE RECOGNITION
Nature of Goods and Services
The Company’s revenue is primarily generated from sales of branded and private label lawn and garden care and indoor and hydroponic gardening finished products to home centers, mass merchandisers, warehouse clubs, large hardware chains, independent hardware stores, nurseries, garden centers, e-commerce platforms, food and drug stores, indoor gardening and hydroponic product distributors, retailers and growers. In addition to product sales, the Company acts as the exclusive agent of Monsanto Company (“Monsanto”) for the marketing and distribution of Monsanto’s consumer Roundup® non-selective weedkiller products in the United States and certain other specified countries, and performs certain other services under ancillary agreements with Monsanto. The Company also provides marketing, research and development and certain ancillary services to Bonnie Plants, Inc. (“Bonnie”). Refer to “NOTE 15. SEGMENT INFORMATION” for disaggregated revenue information and “NOTE 8. MARKETING AGREEMENT” for revenue information related to the Monsanto agreements.
Identification and Satisfaction of Performance Obligations
Product sales are recognized at a point in time when control of products transfers to customers and the Company has no further obligation to provide services related to such products. Control is the ability of customers to direct the “use of” and “obtain” the benefit from the Company’s products. In evaluating the timing of the transfer of control of products to customers, the Company considers several control indicators, including significant risks and rewards of products, the Company’s right to payment and the legal title of the products. Based on the assessment of control indicators, sales are typically recognized when products are delivered to or picked up by the customer. The Company is generally the principal in a transaction, therefore revenue is primarily recorded on a gross basis. When the Company is a principal in a transaction, it has determined that it controls the ability to direct the use of the product prior to transfer to a customer, is primarily responsible for fulfilling the promise to provide the product or service to the customer, has discretion in establishing prices, and ultimately controls the transfer of the product or services provided to the customer.
Under the terms of the Second Amended and Restated Exclusive Agency and Marketing Agreement (the “Restated Marketing Agreement”), pursuant to which the Company serves as the exclusive sales and marketing agent of Monsanto with respect to Monsanto’s consumer Roundup® non-selective weedkiller products in the United States and certain other specified countries, the Company is entitled to receive an annual commission from Monsanto as consideration for the performance of the Company’s duties as agent. The annual commission payable under the Restated Marketing Agreement is equal to (1) 50% of the actual earnings before interest and income taxes of Monsanto’s consumer Roundup® business in the markets covered by the Restated Marketing Agreement for program years 2017 and 2018 and (2) 50% of the actual earnings before interest and income taxes of Monsanto’s consumer Roundup® business in the markets covered by the Restated Marketing Agreement in excess of $40.0 million for program years 2019 and thereafter. The Restated Marketing Agreement also requires the Company to make annual payments of $18.0 million to Monsanto as a contribution against the overall expenses of its consumer Roundup® business. The gross commission earned under the Restated Marketing Agreement and the contribution payments to Monsanto are included in the “Net sales” line in the Condensed Consolidated Statements of Operations. The Company performs other services, including conversion services, pursuant to ancillary agreements with Monsanto. The actual costs incurred for these activities are charged to and reimbursed by Monsanto. The Company records costs incurred for which the Company is the primary obligor on a gross basis, recognizing such costs in the “Cost of sales” line and the reimbursement of these costs in the “Net sales” line in the Condensed Consolidated Statements of Operations, with no effect on gross profit dollars or net income.
Under the terms of the Marketing, R&D and Ancillary Services Agreement (the “Services Agreement”) with Bonnie and its sole shareholder, Alabama Farmers Cooperative, Inc. (“AFC”), the Company provides marketing, research and development and certain ancillary services to Bonnie. In exchange for these services, Bonnie reimburses the Company for certain costs and provides a commission fee earned based on a percentage of the growth in earnings before interest, income taxes and amortization of Bonnie’s business of planting, growing, developing, manufacturing, distributing, marketing, and selling live plants, plant food, fertilizer and potting soil (the “Bonnie Business”). The commission earned under the Services Agreement is included in the “Net sales” line in the Condensed Consolidated Statements of Operations. Additionally, the Company records costs incurred under the Services Agreement for which the Company is the primary obligor on a gross basis, recognizing such costs in the “Cost of sales” line and the reimbursement of these costs in the “Net sales” line in the Condensed Consolidated Statements of Operations, with no effect on gross profit dollars or net income.

10


Transactional Price and Promotional Allowances
Revenue for product sales is recorded net of sales returns and allowances. Revenues are measured based on the amount of consideration that the Company expects to receive as derived from a list price, reduced by estimates for variable consideration. Variable consideration includes the cost of current and continuing promotional programs and expected sales returns. Commission income related to the Monsanto and Bonnie agreements is recognized over the program year as the services are being performed based upon the commission income formula in the agreements.
The Company’s promotional programs primarily include rebates based on sales volumes, in-store promotional allowances, cooperative advertising programs, direct consumer rebate programs and special purchasing incentives. The cost of promotional programs is estimated considering all reasonably available information, including current expectations and historical experience. Promotion costs (including allowances and rebates) incurred during the year are expensed to interim periods in relation to revenues and are recorded as a reduction of net sales. Accruals for expected payouts under these programs are included in the “Other current liabilities” line in the Condensed Consolidated Balance Sheets. Provisions for estimated returns and allowances are recorded at the time revenue is recognized based on historical rates and are periodically adjusted for known changes in return levels. Shipping and handling costs are accounted for as contract fulfillment costs and included in the “Cost of sales” line in the Condensed Consolidated Statements of Operations. The Company excludes from revenue any amounts collected from customers for sales or other taxes.
NOTE 3. DISCONTINUED OPERATIONS
International Business
Prior to August 31, 2017, the Company operated consumer lawn and garden businesses located in Australia, Austria, Belgium, Luxembourg, Czech Republic, France, Germany, Poland and the United Kingdom (the “International Business”). On April 29, 2017, the Company received a binding and irrevocable conditional offer (the “Offer”) from Exponent Private Equity LLP (“Exponent”) to purchase the International Business. On July 5, 2017, the Company accepted the Offer and the Company completed the sale on August 31, 2017. As a result, effective in its fourth quarter of fiscal 2017, the Company classified its results of operations for all periods presented to reflect the International Business as a discontinued operation and classified the assets and liabilities of the International Business as held for sale. During the three months ended March 31, 2018, the Company recorded a reduction to the gain on the sale of the International Business of $3.7 million related to the resolution of the post-closing working capital adjustment obligation.
During the three and six months ended March 31, 2018, the Company recognized $0.2 million and $1.6 million, respectively, in transaction related costs associated with the sale of the International Business.
Wild Bird Food
During fiscal 2014, the Company completed the sale of its U.S. and Canadian wild bird food business. As a result, effective in fiscal 2014, the Company classified its results of operations for all periods presented to reflect the wild bird food business as a discontinued operation. At March 30, 2019, March 31, 2018 and September 30, 2018, $42.5 million, zero and $85.0 million, respectively, was accrued for a probable loss related to the previously disclosed legal matter In re Morning Song Bird Food Litigation in the “Other current liabilities” line in the Condensed Consolidated Balance Sheets. This matter relates to a pending class-action lawsuit filed in 2012 in connection with the sale of wild bird food products that were the subject of a voluntary recall in 2008 by the Company’s previously sold wild bird food business. During the three and six months ended March 30, 2019, the Company received insurance reimbursement payments related to this matter of $8.4 million and $13.4 million, respectively. The Company recognized insurance recoveries of $5.0 million related to this matter in the “Income (loss) from discontinued operations, net of tax” line in the Condensed Consolidated Statements of Operations during the first quarter of fiscal 2019, and the remaining $8.4 million of reimbursements have been recognized as an accrued liability in the Condensed Consolidated Balance Sheets as of March 30, 2019 pending the finalization of the settlement. Refer to “NOTE 12. CONTINGENCIES” for more information.

11


The following table summarizes the results of discontinued operations described above and reflected within discontinued operations in the Company’s condensed consolidated financial statements for each of the periods presented:

THREE MONTHS ENDED
 
SIX MONTHS ENDED
 
MARCH 30,
2019
 
MARCH 31,
2018
 
MARCH 30,
2019
 
MARCH 31,
2018
 
(In millions)
Operating and exit costs
$
0.1

 
$
1.6

 
$
0.1

 
$
1.6

Impairment, restructuring and other charges (recoveries), net

 
0.2

 
(4.9
)
 
1.6

Loss on sale / contribution of business

 
3.7

 

 
3.5

Income (loss) from discontinued operations before income taxes
(0.1
)
 
(5.5
)
 
4.8

 
(6.7
)
Income tax expense (benefit) from discontinued operations
0.4

 
(1.8
)
 
2.3

 
(1.8
)
Income (loss) from discontinued operations, net of tax
$
(0.5
)
 
$
(3.7
)
 
$
2.5

 
$
(4.9
)
The Condensed Consolidated Statements of Cash Flows do not present the cash flows from discontinued operations separately from cash flows from continuing operations. Cash used in operating activities related to discontinued operations totaled $34.7 million and zero for the six months ended March 30, 2019 and March 31, 2018, respectively. Cash used in investing activities related to discontinued operations was zero and $35.3 million for the six months ended March 30, 2019 and March 31, 2018, respectively.
NOTE 4. ACQUISITIONS AND INVESTMENTS
FISCAL 2018
Sunlight Supply
On June 4, 2018, the Company’s Hawthorne segment acquired substantially all of the assets and certain liabilities of Sunlight Supply, Inc., Sunlight Garden Supply, Inc., Sunlight Garden Supply, ULC, and IP Holdings, LLC, and all of the issued and outstanding equity interests of Columbia River Industrial Holdings, LLC (collectively “Sunlight Supply”). Sunlight Supply, based in Vancouver, Washington, is a leading developer, manufacturer, marketer and distributer of horticultural, organics, lighting, and hydroponics products. Prior to the transaction, Sunlight Supply served as a non-exclusive distributor of the Company. The estimated purchase price of Sunlight Supply was $458.6 million, a portion of which was paid by the issuance of 0.3 million common shares of Scotts Miracle-Gro (“Common Shares”), a non-cash investing and financing activity, with a fair value of $23.4 million based on the average share price at the time of payment. The purchase price included contingent consideration, a non-cash investing activity, with an initial fair value of $3.1 million and a maximum payout of $20.0 million, which will be paid by the Company contingent on the achievement of certain performance metrics of the Company through the one-year anniversary of the closing date. The purchase price was also subject to a post-closing net working capital adjustment which was paid during the first quarter of fiscal 2019.
The preliminary valuation of the acquired assets included (i) $5.8 million of cash, prepaid and other current assets, (ii) $19.3 million of accounts receivable, (iii) $84.3 million of inventory, (iv) $64.4 million of fixed assets, (v) $11.7 million of accounts payable and other current liabilities, (vi) $151.1 million of finite-lived identifiable intangible assets, and (vii) $145.4 million of tax-deductible goodwill. Identifiable intangible assets included tradenames of $65.1 million, customer relationships of $84.1 million and non-competes of $1.9 million with useful lives ranging between 5 and 25 years. The estimated fair values of the identifiable intangible assets were determined using an income-based approach, which includes market participant expectations of cash flows that an asset will generate over the remaining useful life discounted to present value using an appropriate discount rate. Certain estimated values for the acquisition, including goodwill, intangible assets, and property, plant and equipment, are not yet finalized and are subject to revision as additional information becomes available and more detailed analysis is completed. The contingent consideration related to the Sunlight Supply acquisition is required to be accounted for as a derivative instrument and is recorded at fair value in the “Other current liabilities” line in the Condensed Consolidated Balance Sheets, with changes in fair value recognized in the “Impairment, restructuring and other” line in the Condensed Consolidated Statements of Operations. The estimated fair value of the contingent consideration was $0.9 million as of March 30, 2019 and the fair value measurement was classified in Level 3 of the fair value hierarchy.
The acquisition of Sunlight Supply also resulted in the settlement of a portion of certain previously acquired customer relationships, which resulted in a non-cash impairment charge of $17.5 million recognized in the “Impairment, restructuring and other” line in the Condensed Consolidated Statements of Operations during the third quarter of fiscal 2018 to reduce the carrying value of these previously acquired customer relationship intangible assets to an estimated fair value of $30.9 million. The estimated fair value was determined using an income-based approach, which includes market participant expectations of cash flows that an

12


asset will generate over the remaining useful life discounted to present value using an appropriate discount rate, and has been included as part of goodwill. Additionally, the Company reduced the value of deferred tax liabilities associated with the write-off of these previously acquired customer relationship intangible assets by $7.3 million, which was recognized in the “Income tax expense (benefit) from continuing operations” line in the Condensed Consolidated Statements of Operations during the third quarter of fiscal 2018.
Net sales for Sunlight Supply included within the Hawthorne segment for the three and six months ended March 30, 2019 were $91.4 million and $163.0 million, respectively. The following unaudited pro forma information presents the combined results of operations as if the acquisition of Sunlight Supply had occurred at the beginning of fiscal 2017. Sunlight Supply’s pre-acquisition results have been added to the Company’s historical results. The pro forma results contained in the table below include adjustments for (i) the elimination of intercompany sales, (ii) amortization of acquired intangibles, (iii) increased depreciation expense as a result of acquisition date fair value adjustments, (iv) increased interest expense related to the financing of the acquisition, (v) adjustments to tax expense based on condensed consolidated pro forma results, and (vi) the impact of Common Shares issued as part of the purchase price in connection with the acquisition. The pro forma information does not reflect the realization of any potential cost savings or other synergies from the acquisition as a result of restructuring activities and other cost savings initiatives. These pro forma results have been prepared for comparative purposes only and are not necessarily indicative of the results of operations as they would have been had the acquisitions occurred on the assumed dates, nor are they necessarily an indication of future operating results.
 
 
THREE MONTHS ENDED
 
SIX MONTHS ENDED
UNAUDITED TOTAL COMPANY CONSOLIDATED PRO FORMA RESULTS
 
MARCH 31, 2018
 
MARCH 31, 2018
 
 
(In millions, except per share data)
Pro forma net sales
 
$
1,095.9

 
$
1,397.1

Pro forma net income attributable to controlling interest
 
150.5

 
129.7

Pro forma diluted net income per common share
 
2.61

 
2.23

Gavita
On May 26, 2016, the Company’s Hawthorne segment acquired majority control and a 75% economic interest in Gavita. Gavita’s former ownership group initially retained a 25% noncontrolling interest in Gavita consisting of ownership of 5% of the outstanding shares of Gavita and a loan with interest payable based on distributions by Gavita. The loan was recorded at fair value in the “Long-term debt” line in the Condensed Consolidated Balance Sheets. On October 2, 2017, the Company’s Hawthorne segment acquired the remaining 25% noncontrolling interest in Gavita, including Agrolux Holding B.V. (now known as Hawthorne Lighting B.V.), and its subsidiaries (collectively, “Agrolux”), for $69.2 million, plus payment of contingent consideration of $3.0 million. The carrying value of the 25% noncontrolling interest consisted of long-term debt of $55.6 million and noncontrolling interest of $7.9 million. The difference between purchase price and carrying value of $5.7 million was recognized in the “Common shares and capital in excess of $0.01 stated value per share” line within “Total equity—controlling interest” in the Condensed Consolidated Balance Sheets. The Company has revised its historical presentation of the payment related to the acquisition of the remaining noncontrolling interest for the six months ended March 31, 2018. This payment was incorrectly classified as an investing activity in the “Investments in acquired businesses, net of cash acquired” line in the Condensed Consolidated Statements of Cash Flows, and was revised to be classified as a financing activity in the “Acquisition of noncontrolling interests” line in the Condensed Consolidated Statements of Cash Flows in accordance with GAAP. The Company previously revised this classification in its fiscal 2018 Form 10–K.
Can-Filters
On October 11, 2017, the Company’s Hawthorne segment completed the acquisition of substantially all of the U.S. and Canadian assets of Can-Filters Group Inc. (“Can-Filters”) for $74.1 million. Based in British Columbia, Can-Filters is a leading wholesaler of ventilation products for indoor and hydroponic gardening and industrial markets worldwide. The valuation of the acquired assets included (i) $1.5 million of cash, prepaid and other current assets, (ii) $7.7 million of inventory and accounts receivable, (iii) $4.4 million of fixed assets, (iv) $0.7 million of accounts payable and other current liabilities, (v) $39.7 million of finite-lived identifiable intangible assets, and (vi) $21.5 million of tax-deductible goodwill. Identifiable intangible assets included tradenames and customer relationships with useful lives of 25 years. The estimated fair value of the identifiable intangible assets were determined using an income-based approach, which includes market participant expectations of cash flows that an asset will generate over the remaining useful life discounted to present value using an appropriate discount rate.

13


NOTE 5. INVESTMENT IN UNCONSOLIDATED AFFILIATES
On March 19, 2019, the Company entered into an agreement under which it sold, to TruGreen Companies L.L.C., a subsidiary of TruGreen Holding Corporation, all of its approximately 30% equity interest in Outdoor Home Services Holdings LLC, a lawn services joint venture between the Company and TruGreen Holding Corporation (the “TruGreen Joint Venture”). Prior to this transaction, the Company’s net investment and advances with respect to the TruGreen Joint Venture had been reduced to a liability which resulted in an amount recorded in the “Distributions in excess of investment in unconsolidated affiliate” line in the Condensed Consolidated Balance Sheets. Under the terms of the agreement, the Company received cash proceeds of $234.2 million related to the sale of its equity interest in the TruGreen Joint Venture and $18.4 million related to the payoff of second lien term loan financing, which was previously recorded in the “Other assets” line in the Condensed Consolidated Balance Sheets. During the three and six months ended March 30, 2019, the Company also received a distribution from the TruGreen Joint Venture intended to cover certain required tax payments of $3.5 million, which was classified as an investing activity in the Condensed Consolidated Statements of Cash Flows. During the three and six months ended March 30, 2019, the Company recognized a pre-tax gain of $259.8 million related to this sale in the “Other non-operating (income) expense, net” line in the Condensed Consolidated Statements of Operations. The Company also reclassified $47.1 million from deferred tax liabilities, which were previously recorded in the “Other liabilities” line in the Condensed Consolidated Balance Sheets, to accrued taxes, which are recorded in the “Other current liabilities” line in the Condensed Consolidated Balance Sheets, related to the outside basis difference in the TruGreen Joint Venture as a result of the sale of the Company’s equity interest.
As of March 30, 2019, the Company held a noncontrolling interest in an unconsolidated affiliate whose products support the professional U.S. industrial, turf and ornamental market (the “IT&O Joint Venture”). During the three and six months ended March 30, 2019, the Company received a distribution of net earnings from the IT&O Joint Venture of $4.9 million, which was classified as an operating activity in the Condensed Consolidated Statements of Cash Flows. On April 1, 2019, the Company sold all of its equity interest in the IT&O Joint Venture for cash proceeds of $36.6 million and a pre-tax gain of approximately $3.0 million will be recognized in the “Other non-operating (income) expense, net” line in the Condensed Consolidated Statements of Operations for the Company’s third quarter of fiscal 2019. The Company provided the IT&O Joint Venture with line of credit financing, which was fully repaid as of March 30, 2019 and had a balance of $7.4 million at March 31, 2018 which was previously recorded in the “Other assets” line in the Condensed Consolidated Balance Sheets.
NOTE 6. IMPAIRMENT, RESTRUCTURING AND OTHER
Activity described herein is classified within the “Cost of sales—impairment, restructuring and other,” “Impairment, restructuring and other” and “Income (loss) from discontinued operations, net of tax” lines in the Condensed Consolidated Statements of Operations.
The following table details impairment, restructuring and other charges (recoveries) for each of the periods presented:
 
THREE MONTHS ENDED
 
SIX MONTHS ENDED
 
MARCH 30,
2019
 
MARCH 31,
2018
 
MARCH 30,
2019
 
MARCH 31,
2018
 
(In millions)
Cost of sales—impairment, restructuring and other:
 
 
 
 
 
 
 
Restructuring and other charges
$
1.0

 
$

 
$
3.0

 
$

Property, plant and equipment impairments

 

 
0.5

 

Operating expenses:
 
 
 
 
 
 
 
Restructuring and other charges, net
0.2

 
10.2

 
3.7

 
10.0

Impairment, restructuring and other charges from continuing operations
$
1.2

 
$
10.2

 
$
7.2

 
$
10.0

Restructuring and other charges (recoveries), net, from discontinued operations

 
0.2

 
(4.9
)
 
1.6

Total impairment, restructuring and other charges
$
1.2

 
$
10.4

 
$
2.3

 
$
11.6


14


The following table summarizes the activity related to liabilities associated with restructuring and other, excluding insurance reimbursement recoveries, during the six months ended March 30, 2019 (in millions):
Amounts accrued for restructuring and other at September 30, 2018
$
112.2

Restructuring and other charges from continuing operations
6.7

Restructuring and other charges from discontinued operations
0.1

Payments and other
(62.7
)
Amounts accrued for restructuring and other at March 30, 2019
$
56.3

Included in restructuring accruals, as of March 30, 2019, is $1.6 million that is classified as long-term. Payments against the long-term accruals will be incurred as the employees covered by the restructuring plan retire or through the passage of time. The remaining amounts accrued will continue to be paid out over the course of the next twelve months.
Project Catalyst
In connection with the acquisition of Sunlight Supply during the third quarter of fiscal 2018, the Company announced the launch of an initiative called Project Catalyst, which is a company-wide restructuring effort to reduce operating costs throughout the U.S. Consumer, Hawthorne and Other segments and drive synergies from recent acquisitions within the Hawthorne segment. During the three and six months ended March 30, 2019, the Company continued to execute on its planned facility closures and consolidations and terminated employees in duplicate roles which resulted in charges of $2.1 million and $7.6 million, respectively, related to Project Catalyst. The Company incurred charges of $0.1 million and $0.4 million in its U.S. Consumer segment, $0.6 million and $2.5 million in its Hawthorne segment and $0.3 million and $0.6 million in its Other segment in the “Cost of sales—impairment, restructuring and other” line in the Condensed Consolidated Statements of Operations during the three and six months ended March 30, 2019, respectively, related to employee termination benefits, facility closure costs and impairment of property, plant and equipment. The Company incurred charges of $0.1 million and $0.5 million in its U.S. Consumer segment, $0.4 million and $2.1 million in its Hawthorne segment, $0.5 million and $0.6 million in its Other segment and $0.1 million and $0.9 million at Corporate in the “Impairment, restructuring and other” line in the Condensed Consolidated Statements of Operations during the three and six months ended March 30, 2019, respectively, related to employee termination benefits and facility closure costs. Costs incurred to date since the inception of Project Catalyst are $22.4 million for the Hawthorne segment, $12.5 million for the U.S. Consumer segment, $1.2 million for the Other segment and $0.9 million for Corporate.
Project Focus
In the first quarter of fiscal 2016, the Company announced a series of initiatives called Project Focus designed to maximize the value of its non-core assets and focus on emerging categories of the lawn and garden industry in its core U.S. business. During the three and six months ended March 31, 2018, the U.S. Consumer segment recognized adjustments of $0.1 million and $0.3 million, respectively, related to previously recognized termination benefits associated with Project Focus in the “Impairment, restructuring and other” line in the Condensed Consolidated Statements of Operations. Costs incurred to date since the inception of the current Project Focus initiatives are $10.0 million for the U.S. Consumer segment, $0.9 million for the Hawthorne segment and $1.2 million for the Other segment, related to transaction activity, termination benefits and facility closure costs.
On August 31, 2017, the Company completed the sale of the International Business. Refer to “NOTE 3. DISCONTINUED OPERATIONS” for more information. During the three and six months ended March 31, 2018, the Company recognized $0.2 million and $1.6 million, respectively, in transaction related costs associated with the sale of the International Business in the “Income (loss) from discontinued operations, net of tax” line in the Condensed Consolidated Statements of Operations.
Other
During the three and six months ended March 30, 2019, the Company received insurance reimbursement payments related to the previously disclosed legal matter In re Morning Song Bird Food Litigation of $8.4 million and $13.4 million, respectively. The Company recognized insurance recoveries of $5.0 million related to this matter in the “Income (loss) from discontinued operations, net of tax” line in the Condensed Consolidated Statements of Operations during the first quarter of fiscal 2019, and the remaining $8.4 million of reimbursements have been recognized as an accrued liability on the Condensed Consolidated Balance Sheets as of March 30, 2019 pending the finalization of the settlement. Refer to “NOTE 12. CONTINGENCIES” for more information.
During the three and six months ended March 30, 2019, the Company recognized favorable adjustments of $0.9 million and $0.4 million, respectively, related to the previously disclosed legal matter In re Scotts EZ Seed Litigation in the “Impairment, restructuring and other” line in the Condensed Consolidated Statements of Operations. During the three and six months ended March 31, 2018, the Company recognized a charge of $10.2 million for a probable loss related to this matter in the “Impairment, restructuring and other” line in the Condensed Consolidated Statements of Operations. Refer to “NOTE 12. CONTINGENCIES” for more information.

15


NOTE 7. INVENTORIES
Inventories consisted of the following for each of the periods presented:
 
MARCH 30,
2019
 
MARCH 31,
2018
 
SEPTEMBER 30,
2018
 
(In millions)
Finished goods
$
469.8

 
$
395.8

 
$
292.1

Work-in-process
63.6

 
61.2

 
60.1

Raw materials
141.9

 
139.9

 
129.2

Total inventories
$
675.3

 
$
596.9

 
$
481.4

Adjustments to reflect inventories at net realizable values were $8.1 million at March 30, 2019, $11.9 million at March 31, 2018 and $8.1 million at September 30, 2018.
NOTE 8. MARKETING AGREEMENT
The Scotts Company LLC (“Scotts LLC”) is the exclusive agent of Monsanto for the marketing and distribution of Monsanto’s consumer Roundup® non-selective weedkiller products in the consumer lawn and garden market in the United States and certain other specified countries pursuant to the Restated Marketing Agreement. The Restated Marketing Agreement covers Israel, China and every country in North America and South America that is not subject to a comprehensive U.S. trade embargo or certain other embargoes and trade restrictions.
Unless Monsanto terminates the Restated Marketing Agreement due to an event of default by the Company, upon a termination of the Restated Marketing Agreement by Monsanto, in addition to other remedies that may be available to the Company, the Restated Marketing Agreement requires a termination fee payable to the Company equal to the greater of (1) $175.0 million or (2) four times (A) the average of the program earnings before interest and income taxes for the three trailing program years prior to the year of termination, minus (B) $186.4 million (the “Termination Fee”). The Company may terminate the Restated Marketing Agreement upon a material breach of the Restated Marketing Agreement by Monsanto or upon a material fraud or material willful misconduct committed by Monsanto, among other potential remedies, and in the event of such a termination by the Company, Monsanto is required to pay to the Company an amount equal to the Termination Fee. Upon a significant decline in either (i) Monsanto’s consumer Roundup® business of more than 25% compared to program year 2014; or (ii) the Roundup® brand, subject to certain terms and conditions, the Company may either terminate the Restated Marketing Agreement or continue the Restated Marketing Agreement and be entitled to receive an additional commission amount. The Restated Marketing Agreement also provides the Company with additional rights and remedies, including the right to terminate the Restated Marketing Agreement in certain circumstances and the right to indemnification for product liability claims relating to its marketing and distribution of Monsanto’s consumer Roundup® products in its capacity as Monsanto’s agent. The term of the Restated Marketing Agreement will continue indefinitely for all included markets unless and until otherwise terminated in accordance therewith. Subsequent to March 30, 2019, Monsanto agreed to reimburse the Company for $20.0 million of additional expenses incurred and to be incurred by the Company for certain activities connected to the Restated Marketing Agreement. The $20.0 million payment will be included in the “Net sales” line in the Condensed Consolidated Statements of Operations for the third quarter of fiscal 2019.
The elements of the net commission and reimbursements earned under the Restated Marketing Agreement and included in “Net sales” are as follows:
 
THREE MONTHS ENDED
 
SIX MONTHS ENDED
 
MARCH 30,
2019
 
MARCH 31,
2018
 
MARCH 30,
2019
 
MARCH 31,
2018
 
(In millions)
Gross commission
$
23.9

 
$
34.5

 
$
23.9

 
$
34.6

Contribution expenses
(4.5
)
 
(4.5
)
 
(9.0
)
 
(9.0
)
Amortization of marketing fee

 
(0.2
)
 

 
(0.4
)
Net commission
19.4

 
29.8

 
14.9

 
25.2

Reimbursements associated with Restated Marketing Agreement
14.4

 
19.7

 
27.0

 
32.5

Total net sales associated with Restated Marketing Agreement
$
33.8

 
$
49.5

 
$
41.9

 
$
57.7



16


NOTE 9. DEBT
The components of the Company’s debt are as follows:
 
MARCH 30,
2019
 
MARCH 31,
2018
 
SEPTEMBER 30,
2018
 
(In millions)
Credit Facilities:
 
 
 
 
 
Revolving loans
$
666.2

 
$
1,043.2

 
$
492.2

Term loans
770.0

 
266.3

 
790.0

Senior Notes – 5.250%
250.0

 
250.0

 
250.0

Senior Notes – 6.000%
400.0

 
400.0

 
400.0

Receivables facility
300.0

 
300.0

 
76.0

Other
19.1

 
22.0

 
17.5

Total debt
2,405.3

 
2,281.5

 
2,025.7

Less current portions
357.7

 
335.8

 
132.6

Less unamortized debt issuance costs
8.5

 
8.0

 
9.3

Long-term debt
$
2,039.1

 
$
1,937.7

 
$
1,883.8

Credit Facilities
On July 5, 2018, the Company entered into a fifth amended and restated credit agreement (the “Fifth A&R Credit Agreement”), providing the Company and certain of its subsidiaries with five-year senior secured loan facilities in the aggregate principal amount of $2.3 billion, comprised of a revolving credit facility of $1.5 billion and a term loan in the original principal amount of $800.0 million (the “Fifth A&R Credit Facilities”).
At March 30, 2019, the Company had letters of credit outstanding in the aggregate principal amount of $21.4 million, and $812.3 million of borrowing availability under the Fifth A&R Credit Agreement. The weighted average interest rates on average borrowings under the Fifth A&R Credit Agreement and the former credit agreement were 4.6% and 4.1% for the six months ended March 30, 2019 and March 31, 2018, respectively.
The Fifth A&R Credit Agreement contains, among other obligations, an affirmative covenant regarding the Company’s leverage ratio on the last day of each quarter calculated as average total indebtedness, divided by the Company’s earnings before interest, taxes, depreciation and amortization (“EBITDA”), as adjusted pursuant to the terms of the Fifth A&R Credit Agreement (“Adjusted EBITDA”). The maximum leverage ratio is: (i) 5.25 through the second quarter of fiscal 2019, (ii) 5.00 for the third quarter of fiscal 2019 through the first quarter of fiscal 2020, (iii) 4.75 for the second quarter of fiscal 2020 through the fourth quarter of fiscal 2020 and (iv) 4.50 for the first quarter of fiscal 2021 and thereafter. The Company’s leverage ratio was 3.93 at March 30, 2019. The Fifth A&R Credit Agreement also contains an affirmative covenant regarding the Company’s interest coverage ratio determined as of the end of each of its fiscal quarters. The interest coverage ratio is calculated as Adjusted EBITDA divided by interest expense, as described in the Fifth A&R Credit Agreement, and excludes costs related to refinancings. The minimum interest coverage ratio was 3.00 for the twelve months ended March 30, 2019. The Company’s interest coverage ratio was 5.67 for the twelve months ended March 30, 2019. The Fifth A&R Credit Agreement allows the Company to make unlimited restricted payments (as defined in the Fifth A&R Credit Agreement), including dividend payments and Common Share repurchases, as long as the leverage ratio resulting from the making of such restricted payments is 4.00 or less. Otherwise the Company may make further restricted payments in an aggregate amount for each fiscal year not to exceed the amount set forth in the Fifth A&R Credit Agreement for such fiscal year ($200.0 million for fiscal 2019 and $225.0 million for fiscal 2020 and thereafter).
Receivables Facility
Under the Master Repurchase Agreement (including the annexes thereto, the “Repurchase Agreement”) and a Master Framework Agreement (the “Framework Agreement” and, together with the Repurchase Agreement, the “Receivables Facility”), as amended, the Company may sell a portfolio of available and eligible outstanding customer accounts receivable to the purchasers and simultaneously agree to repurchase the receivables on a weekly basis. The Company accounts for the sale of receivables under the Receivables Facility as short-term debt and continues to carry the receivables on its Condensed Consolidated Balance Sheets, primarily as a result of the Company’s requirement to repurchase receivables sold. As of March 30, 2019 and March 31, 2018, there were $300.0 million in borrowings on receivables pledged as collateral under the Receivables Facility, and the carrying value of the receivables pledged as collateral was $333.3 million. As of March 30, 2019 and March 31, 2018, there was $100.0 million and $78.4 million, respectively, of availability under the Receivables Facility.

17


Interest Rate Swap Agreements
The Company has outstanding interest rate swap agreements with major financial institutions that effectively convert a portion of the Company’s variable-rate debt to a fixed rate. The swap agreements had a maximum total U.S. dollar equivalent notional amount of $1,300.0 million at March 30, 2019, $1,300.0 million at March 31, 2018 and $800.0 million at September 30, 2018, respectively. Interest payments made between the effective date and expiration date are hedged by the swap agreements, except as noted below.
The notional amount, effective date, expiration date and rate of each of these swap agreements outstanding at March 30, 2019 are shown in the table below:
Notional Amount
(in millions)
 
Effective
Date (a)
 
Expiration
Date
 
Fixed
Rate
$
150

(b)  
2/7/2017
 
5/7/2019
 
2.12
%
50

(b)  
2/7/2017
 
5/7/2019
 
2.25
%
50

 
2/28/2018
 
5/28/2019
 
2.01
%
200

(c) 
12/20/2016
 
6/20/2019
 
2.12
%
250

(d) 
1/8/2018
 
6/8/2020
 
2.09
%
100

 
6/20/2018
 
10/20/2020
 
2.15
%
200

(d) 
11/7/2018
 
6/7/2021
 
2.87
%
100

 
11/7/2018
 
7/7/2021
 
2.96
%
200

 
11/7/2018
 
10/7/2021
 
2.98
%

(a)
The effective date refers to the date on which interest payments were first hedged by the applicable swap agreement.
(b)
Interest payments made during the three-month period of each year that begins with the month and day of the effective date are hedged by the swap agreement.
(c)
Interest payments made during the six-month period of each year that begins with the month and day of the effective date are hedged by the swap agreement.
(d)
Notional amount adjusts in accordance with a specified seasonal schedule. This represents the maximum notional amount at any point in time.
Estimated Fair Values
The methods and assumptions used to estimate the fair values of the Company’s debt instruments are described below:
Credit Facilities
The interest rate currently available to the Company fluctuates with the applicable LIBO rate, prime rate or Federal Funds Effective Rate and thus the carrying value is a reasonable estimate of fair value. The fair value measurement for the Fifth A&R Credit Facilities was classified in Level 2 of the fair value hierarchy.
5.250% Senior Notes
The fair value of the 5.250% Senior Notes was determined based on the trading of the 5.250% Senior Notes in the open market. The difference between the carrying value and the fair value of the 5.250% Senior Notes represents the premium or discount on that date. Based on the trading value on or around March 30, 2019, the fair value of the 5.250% Senior Notes was approximately $245.0 million. The fair value measurement for the 5.250% Senior Notes was classified in Level 1 of the fair value hierarchy.
6.000% Senior Notes
The fair value of the 6.000% Senior Notes was determined based on the trading of the 6.000% Senior Notes in the open market. The difference between the carrying value and the fair value of the 6.000% Senior Notes represents the premium or discount on that date. Based on the trading value on or around March 30, 2019, the fair value of the 6.000% Senior Notes was approximately $416.0 million. The fair value measurement for the 6.000% Senior Notes was classified in Level 1 of the fair value hierarchy.
Accounts Receivable Pledged
The interest rate on the short-term debt associated with accounts receivable pledged under the Receivables Facility fluctuated with the applicable LIBOR and thus the carrying value is a reasonable estimate of fair value. The fair value measurement for the Receivables Facility was classified in Level 2 of the fair value hierarchy.

18


Weighted Average Interest Rate
The weighted average interest rates on the Company’s debt were 4.7% and 4.4% for the six months ended March 30, 2019 and March 31, 2018, respectively.
NOTE 10. EQUITY
The following table provides a summary of the changes in total equity, equity attributable to controlling interest, and equity attributable to noncontrolling interests for the three and six months ended March 30, 2019 (in millions):
 
Common Shares and Capital in
Excess of Stated Value
 
Retained
Earnings
 
Treasury
Shares
 
Accumulated Other
Comprehensive Loss
 
Total Equity -
Controlling Interest
 
Non-controlling
Interest
 
Total
Equity
Balance at September 30, 2018
$
420.3

 
$
919.9

 
$
(939.6
)
 
$
(46.0
)
 
$
354.6

 
$
5.0

 
$
359.6

Adoption of new accounting pronouncements (see Note 1)

 
26.0

 

 
(16.9
)
 
9.1

 

 
9.1

Net income (loss)

 
(79.6
)
 

 

 
(79.6
)
 
(0.1
)
 
(79.7
)
Other comprehensive income (loss)

 

 

 
(12.4
)
 
(12.4
)
 

 
(12.4
)
Share-based compensation
6.6

 

 

 

 
6.6

 

 
6.6

Dividends declared ($0.550 per share)

 
(30.9
)
 

 

 
(30.9
)
 

 
(30.9
)
Treasury share issuances
(1.0
)
 

 
1.9

 

 
0.9

 

 
0.9

Balance at December 29, 2018
$
425.9

 
$
835.4

 
$
(937.7
)
 
$
(75.3
)
 
$
248.3

 
$
4.9

 
$
253.2

Net income (loss)

 
396.5

 

 

 
396.5

 
(0.1
)
 
396.4

Other comprehensive income (loss)

 

 

 
(3.9
)
 
(3.9
)
 

 
(3.9
)
Share-based compensation
10.4

 

 

 

 
10.4

 

 
10.4

Dividends declared ($0.550 per share)

 
(32.7
)
 

 

 
(32.7
)
 

 
(32.7
)
Treasury share purchases

 

 
(2.5
)
 

 
(2.5
)
 

 
(2.5
)
Treasury share issuances
(10.1
)
 

 
11.2

 

 
1.1

 

 
1.1

Balance at March 30, 2019
$
426.2

 
$
1,199.2

 
$
(929.0
)
 
$
(79.2
)
 
$
617.2

 
$
4.9

 
$
622.1

The sum of the components may not equal due to rounding.

19


The following table provides a summary of the changes in total equity, equity attributable to controlling interest, and equity attributable to noncontrolling interests for the three and six months ended March 31, 2018 (in millions):
 
Common Shares and Capital in
Excess of Stated Value
 
Retained
Earnings
 
Treasury
Shares
 
Accumulated Other
Comprehensive Loss
 
Total Equity -
Controlling Interest
 
Non-controlling
Interest
 
Total
Equity
Balance at September 30, 2017
$
407.6

 
$
978.2

 
$
(667.8
)
 
$
(69.2
)
 
$
648.8

 
$
12.9

 
$
661.7

Net income (loss)

 
(21.2
)
 

 

 
(21.2
)
 

 
(21.2
)
Other comprehensive income (loss)

 

 

 
1.0

 
1.0

 

 
1.0

Share-based compensation
6.0

 

 

 

 
6.0

 

 
6.0

Dividends declared ($0.530 per share)

 
(31.1
)
 

 

 
(31.1
)
 

 
(31.1
)
Treasury share purchases

 

 
(96.6
)
 

 
(96.6
)
 

 
(96.6
)
Treasury share issuances

 

 
1.6

 

 
1.6

 

 
1.6

Acquisition of remaining noncontrolling interest in Gavita
(5.7
)
 

 

 

 
(5.7
)
 
(7.9
)
 
(13.6
)
Balance at December 30, 2017
$
407.9

 
$
925.9

 
$
(762.8
)
 
$
(68.2
)
 
$
502.8

 
$
5.0

 
$
507.8

Net income (loss)

 
148.9

 

 

 
148.9

 
0.1

 
149.0

Other comprehensive income (loss)

 

 

 
17.0

 
17.0

 

 
17.0

Share-based compensation
9.7

 

 

 

 
9.7

 

 
9.7

Dividends declared ($0.530 per share)

 
(30.3
)
 

 

 
(30.3
)
 

 
(30.3
)
Treasury share purchases

 

 
(160.2
)
 

 
(160.2
)
 

 
(160.2
)
Treasury share issuances
(8.6
)
 

 
11.6

 

 
3.0

 

 
3.0

Balance at March 30, 2018
$
409.0

 
$
1,044.5

 
$
(911.4
)
 
$
(51.3
)
 
$
490.8

 
$
5.1

 
$
495.9

The sum of the components may not equal due to rounding.
Accumulated Other Comprehensive Loss
During the three and six months ended March 30, 2019, the Company recognized a charge of $2.5 million in the “Other non-operating (income) expense, net” line in the Condensed Consolidated Statements of Operations related to the write-off of accumulated foreign currency translation loss adjustments of a foreign subsidiary that was substantially liquidated. During the three and six months ended March 31, 2018, the Company repatriated cash from a foreign subsidiary resulting in the liquidation of substantially all of the assets of the subsidiary and the write-off of accumulated foreign currency translation loss adjustments of $11.7 million within the “Other non-operating (income) expense, net” line in the Condensed Consolidated Statements of Operations.
Share Repurchases
In August 2014, the Scotts Miracle-Gro Board of Directors authorized the repurchase of up to $500.0 million of Common Shares over a five-year period (effective November 1, 2014 through September 30, 2019). On August 3, 2016, Scotts Miracle-Gro announced that its Board of Directors authorized a $500.0 million increase to the share repurchase authorization ending on September 30, 2019. The amended authorization allows for repurchases of Common Shares of up to an aggregate amount of $1.0 billion through September 30, 2019. The authorization provides the Company with flexibility to purchase Common Shares from time to time in open market purchases or through privately negotiated transactions. All or part of the repurchases may be made under Rule 10b5-1 plans, which the Company may enter into from time to time and which enable the repurchases to occur on a more regular basis, or pursuant to accelerated share repurchases. The share repurchase authorization, which expires September 30, 2019, may be suspended or discontinued by the Board of Directors at any time, and there can be no guarantee as to the timing or amount of any repurchases. There were no share repurchases under the program during the three and six months ended March 30, 2019. During the three and six months ended March 31, 2018, Scotts Miracle-Gro repurchased 1.7 million and 2.7 million Common Shares for $160.2 million and $256.8 million, respectively. From the inception of this share repurchase program in the fourth quarter of fiscal 2014 through March 30, 2019, Scotts Miracle-Gro repurchased approximately 8.3 million Common Shares for $714.6 million. The “Treasury share purchases” lines in the tables above include cash paid to tax authorities to satisfy statutory income tax withholding obligations related to share-based compensation of $2.5 million for the three and six months ended March 30, 2019, and $2.8 million and $2.9 million for the three and six months ended March 31, 2018, respectively.
 

20


Acquisition of Sunlight Supply
On June 4, 2018, Scotts Miracle-Gro issued 0.3 million Common Shares, which represented a carrying value of $20.7 million, out of its treasury shares for payment of a portion of the purchase price for the acquisition of Sunlight Supply.
Gavita
On October 2, 2017, the Company’s Hawthorne segment acquired the remaining 25% noncontrolling interest in Gavita, including Agrolux, for $69.2 million, plus payment of contingent consideration of $3.0 million. The carrying value of the 25% noncontrolling interest consisted of long-term debt of $55.6 million and noncontrolling interest of $7.9 million. The difference between purchase price and carrying value of $5.7 million was recognized in the “Common shares and capital in excess of $0.01 stated value per share” line within “Total equity—controlling interest” in the Condensed Consolidated Balance Sheets.
Share-Based Awards
Scotts Miracle-Gro grants share-based awards annually to officers and certain other employees of the Company and non-employee directors of Scotts Miracle-Gro. The share-based awards have consisted of stock options, restricted stock units, deferred stock units and performance-based awards. All of these share-based awards have been made under plans approved by the shareholders of Scotts Miracle-Gro. If available, Scotts Miracle-Gro will typically use treasury shares, or if not available, newly-issued Common Shares, in satisfaction of its share-based awards.
On October 30, 2017, Scotts Miracle-Gro issued 0.2 million upfront performance-based award units (the “Hawthorne PFAs”), covering a four-year performance period, with an estimated fair value of $20.2 million on the date of grant, to certain Hawthorne segment employees as part of its Project Focus initiative. These awards were to vest after approximately four years subject to the achievement of specific performance goals aligned with the strategic objectives of the Company’s Project Focus initiatives. Based on the extent to which the performance goals were achieved, vested shares were to range from 50 to 250 percent of the target award amount. The performance goals were based on cumulative Hawthorne non-GAAP adjusted earnings. These performance-based award units were to accrue cash dividend equivalents payable upon vesting of the awards. During the first quarter of fiscal 2019, in light of Hawthorne’s acquisition of Sunlight Supply and the fiscal 2018 downturn in the Hawthorne business, the Company authorized the cancellation of the Hawthorne PFAs and the issuance of a one-time performance bonus grant for certain Hawthorne segment employees with targets based on specified levels of Hawthorne non-GAAP adjusted earnings, subject to participant consent.
The following is a summary of the share-based awards granted during each of the periods indicated:
 
SIX MONTHS ENDED
 
MARCH 30,
2019
 
MARCH 31,
2018
Employees
 
 
 
Restricted stock units
161,322

 
109,563

Performance units
68,949

 
235,503

Board of Directors
 
 
 
Deferred stock units
29,995

 
20,799

Total share-based awards
260,266

 
365,865

 
 
 
 
Aggregate fair value at grant dates (in millions)
$
19.6

 
$
34.9

Total share-based compensation was as follows for each of the periods indicated:
 
THREE MONTHS ENDED
 
SIX MONTHS ENDED
 
MARCH 30,
2019
 
MARCH 31,
2018
 
MARCH 30,
2019
 
MARCH 31,
2018
 
(In millions)
Share-based compensation
$
10.4

 
$
9.7

 
$
17.0

 
$
15.7

Tax benefit recognized
1.7

 
1.8

 
3.4

 
4.1


21


Stock Options
Aggregate stock option activity for the six months ended March 30, 2019 was as follows:
 
No. of
  Options
 
Wtd.
Avg.
Exercise
Price
Awards outstanding at September 30, 2018
1,217,092

 
$
58.68

Granted

 

Exercised
(28,953
)
 
52.99

Forfeited

 

Awards outstanding at March 30, 2019
1,188,139

 
58.82

Exercisable
1,188,139

 
58.82

At March 30, 2019, the total pre-tax compensation cost, net of estimated forfeitures, related to nonvested stock options not yet recognized was zero. The total intrinsic value of stock options exercised was $0.6 million for the six months ended March 30, 2019.  Cash received from the exercise of stock options, including amounts received from employee purchases under the employee stock purchase plan, was $2.3 million for the six months ended March 30, 2019. The following summarizes certain information pertaining to stock option awards outstanding and exercisable at March 30, 2019 (options in millions): 
 
 
Awards Outstanding
 
Awards Exercisable
Range of
Exercise Price
 
No. of
Options
 
Wtd.
Avg.
Remaining
Life
 
Wtd.
Avg.
Exercise
Price
 
No. of
Options
 
Wtd.
Avg.
Remaining
Life
 
Wtd.
Avg.
Exercise
Price
$38.81 – $49.19
 
0.4

 
1.98
 
$
45.39

 
0.4

 
1.98
 
$
45.39

$63.43 – $68.68
 
0.8

 
6.37
 
66.24

 
0.8

 
6.37
 
66.24

 
 
1.2

 
4.80
 
58.82

 
1.2

 
4.80
 
58.82

The intrinsic values of the stock option awards outstanding and exercisable at March 30, 2019 were as follows (in millions): 
Outstanding
$
23.5

Exercisable
23.5

Restricted share-based awards
Restricted share-based award activity (including restricted stock units and deferred stock units) for the six months ended March 30, 2019 was as follows:
 
No. of
Shares
 
Wtd. Avg.
Grant Date
Fair Value
per Share
Awards outstanding at September 30, 2018
403,440

 
$
87.42

Granted
191,317

 
75.69

Vested
(87,472
)
 
71.16

Forfeited
(11,054
)
 
89.74

Awards outstanding at March 30, 2019
496,231

 
85.71

At March 30, 2019, the total pre-tax compensation cost, net of estimated forfeitures, related to nonvested restricted share units not yet recognized was $14.0 million, which is expected to be recognized over a weighted-average period of 2.1 years. The total fair value of restricted stock units and deferred stock units vested was $6.2 million for the six months ended March 30, 2019.

22


Performance-based awards
Performance-based award activity for the six months ended March 30, 2019 was as follows (based on target award amounts):
 
No. of
Units
 
Wtd. Avg.
Grant Date
Fair Value
per Unit
Awards outstanding at September 30, 2018
755,807

 
$
92.96

Granted
68,949

 
74.28

Vested
(56,315
)
 
68.68

Forfeited
(84,775
)
 
97.74

Awards outstanding at March 30, 2019
683,666

 
91.84

At March 30, 2019, the total pre-tax compensation cost, net of estimated forfeitures, related to nonvested performance-based units not yet recognized was $26.8 million, which is expected to be recognized over a weighted-average period of 2.5 years. The total fair value of performance-based units vested was $3.9 million for the six months ended March 30, 2019.
NOTE 11. INCOME TAXES
The effective tax rates related to continuing operations for the six months ended March 30, 2019 and March 31, 2018 were 24.7% and (15.0)%, respectively. The effective tax rate used for interim reporting purposes is based on management’s best estimate of factors impacting the effective tax rate for the full fiscal year and includes the impact of discrete items recognized in the quarter. There can be no assurance that the effective tax rate estimated for interim financial reporting purposes will approximate the effective tax rate determined at fiscal year end. During the six months ended March 31, 2018, the Company recognized a one-time $45.9 million net tax benefit adjustment reflecting the revaluation of its net deferred tax liability at the lower tax rate under the Act. In addition, as part of the Act, the Company recognized a one-time tax expense on deemed repatriated earnings and cash of foreign subsidiaries as required by the Act of $14.0 million, partially offset by the recognition and application of foreign tax credits associated with these foreign subsidiaries of $13.9 million.
SAB 118 provides guidance on accounting for the tax effects of the Act. In accordance with SAB 118, any necessary measurement adjustments were recorded and disclosed within one year from the enactment date within the period the adjustments are determined. Accordingly, the Company accounted for the various elements of the Act as follows:
Statutory Tax Rate Reduction: The Act reduced the federal corporate statutory tax rate to 21% effective January 1, 2018. As the Company’s fiscal year end falls on September 30, the federal corporate statutory tax rate for fiscal 2018 was prorated to 24.5%, with the statutory tax rate for fiscal 2019 and beyond at 21%. As a result of the reduction in statutory tax rate, the Company recorded a reduction in the value of its net deferred tax liability and a net benefit of $44.6 million was recorded in the “Income tax expense from continuing operations” line in the Consolidated Statements of Operations during fiscal 2018.
Deemed Repatriation Transition Tax: The Act requires companies to pay a mandatory one-time U.S. transition tax on deemed repatriation of certain undistributed earnings of foreign subsidiaries. For fiscal 2018, the Company estimated U.S. federal tax on the deemed repatriation of $21.2 million based on $97.8 million of undistributed earnings of foreign subsidiaries. This expense is largely offset by $18.2 million of foreign tax credits, $0.5 million of which was carried forward from prior periods and offset by a complete valuation allowance.
Other Provisions of the Act: Certain other aspects of the Act not expected to have a material effect on the Company’s financial statements are effective for fiscal year 2019 including those related to performance based compensation and others related to international taxation such as Global Intangible Low-Taxed Income (“GILTI”), Foreign Derived Intangible Income (“FDII”), and the Base Erosion Anti-Abuse Tax (“BEAT”). The Company has elected to account for GILTI under the period cost method. Estimates for these provisions have been included as components of the Company’s annualized effective tax rate and recorded in the “Income tax expense (benefit) from continuing operations” line in the Condensed Consolidated Statements of Operations for the six months ended March 30, 2019.
The Company’s net deferred tax liability decreased by $37.5 million during the six months ended March 30, 2019. This decrease was primarily comprised of the reclassification of deferred tax liabilities of $47.1 million to accrued taxes related to the outside basis difference in the TruGreen Joint Venture as the result of the sale of the Company’s equity interest, partially offset by the reclassification of deferred tax assets of $13.9 million to accrued taxes as a result of payments made in connection with litigation settlements.

23


Scotts Miracle-Gro or one of its subsidiaries files income tax returns in the U.S. federal jurisdiction and various state, local and foreign jurisdictions. The Company is currently under examination by certain U.S. state and local tax authorities for tax periods limited to fiscal years 2009 through 2017. Other than these examinations, the Company is no longer subject to examination by tax authorities for fiscal years prior to 2015. In addition to the aforementioned audits, certain other tax deficiency notices and refund claims for previous years remain unresolved.
The Company anticipates that few of its open and active audits will be resolved within the next twelve months. The Company is unable to make a reasonably reliable estimate as to when or if cash settlements with taxing authorities may occur. Although audit outcomes and the timing of audit payments are subject to significant uncertainty, the Company does not anticipate that the resolution of these tax matters or any events related thereto will result in a material change to its consolidated financial position, results of operations or cash flows.
NOTE 12. CONTINGENCIES
Management regularly evaluates the Company’s contingencies, including various lawsuits and claims which arise in the normal course of business, product and general liabilities, workers’ compensation, property losses and other liabilities for which the Company is self-insured or retains a high exposure limit. Self-insurance accruals are established based on actuarial loss estimates for specific individual claims plus actuarially estimated amounts for incurred but not reported claims and adverse development factors applied to existing claims. Legal costs incurred in connection with the resolution of claims, lawsuits and other contingencies generally are expensed as incurred. In the opinion of management, the assessment of contingencies is reasonable and related accruals, in the aggregate, are adequate; however, there can be no assurance that final resolution of these matters will not have a material effect on the Company’s financial condition, results of operations or cash flows.
Regulatory Matters
At March 30, 2019, $3.9 million was accrued in the “Other liabilities” line in the Condensed Consolidated Balance Sheets for environmental actions, the majority of which are for site remediation. The amounts accrued are believed to be adequate to cover such known environmental exposures based on current facts and estimates of likely outcomes. Although it is reasonably possible that the costs to resolve such known environmental exposures will exceed the amounts accrued, any variation from accrued amounts is not expected to be material.
Other
The Company has been named as a defendant in a number of cases alleging injuries that the lawsuits claim resulted from exposure to asbestos-containing products, apparently based on the Company’s historic use of vermiculite in certain of its products. In many of these cases, the complaints are not specific about the plaintiffs’ contacts with the Company or its products. The cases vary, but complaints in these cases generally seek unspecified monetary damages (actual, compensatory, consequential and punitive) from multiple defendants. The Company believes that the claims against it are without merit and is vigorously defending against them. No accruals have been recorded in the Company’s consolidated financial statements as the likelihood of a loss is not probable at this time; and the Company does not believe a reasonably possible loss would be material to, nor the ultimate resolution of these cases will have a material adverse effect on, the Company’s financial condition, results of operations or cash flows. There can be no assurance that future developments related to pending claims or claims filed in the future, whether as a result of adverse outcomes or as a result of significant defense costs, will not have a material effect on the Company’s financial condition, results of operations or cash flows.
In connection with the sale of wild bird food products that were the subject of a voluntary recall in 2008, the Company, along with its Chief Executive Officer, have been named as defendants in four actions filed on and after June 27, 2012, which have been consolidated, and, on March 31, 2017, certified as a class action in the United States District Court for the Southern District of California as In re Morning Song Bird Food Litigation, Lead Case No. 3:12-cv-01592-JAH-AGS. The plaintiffs allege various statutory and common law claims associated with the Company’s sale of wild bird food products and a plea agreement entered into in previously pending government proceedings associated with such sales. The plaintiffs allege, among other things, a class action on behalf of all persons and entities in the United States who purchased certain bird food products. The plaintiffs assert: (i) hundreds of millions of dollars in monetary damages (actual, compensatory, consequential, and restitution); (ii) punitive and treble damages; (iii) injunctive and declaratory relief; (iv) pre-judgment and post-judgment interest; and (v) costs and attorneys’ fees. The Company and its Chief Executive Officer dispute the plaintiffs’ assertions and have vigorously defended the consolidated action. The parties reached an agreement to settle this matter, which the parties memorialized in a settlement agreement submitted to the Court for approval on December 7, 2018. On January 31, 2019, the Court preliminarily approved the settlement, and scheduled a final fairness hearing for June 3, 2019. During the three months ended March 30, 2019, the Company paid $42.5 million to the settlement fund in accordance with the settlement agreement. At March 30, 2019, March 31, 2018 and September 30, 2018, $42.5 million, zero and $85.0 million, respectively, was accrued for a probable loss related to this matter in the “Other current liabilities” line in the Condensed Consolidated Balance Sheets. During the three and six months ended March 30, 2019, the Company received

24


insurance reimbursement payments related to this matter of $8.4 million and $13.4 million, respectively. The Company recognized insurance recoveries of $5.0 million related to this matter in the “Income (loss) from discontinued operations, net of tax” line in the Condensed Consolidated Statements of Operations during the first quarter of fiscal 2019, and the remaining $8.4 million of reimbursements have been recognized as an accrued liability in the Condensed Consolidated Balance Sheets as of March 30, 2019 pending the finalization of the settlement. There can be no assurance that future developments with respect to this action, whether as a result of an adverse outcome or as a result of significant defense costs, will not have a material adverse effect on the Company’s financial condition, results of operations or cash flows.
The Company was named as a defendant in In re Scotts EZ Seed Litigation, Case No. 12-cv-4727 (VB), a New York and California class action lawsuit filed August 9, 2012 in the United States District Court for the Southern District of New York that asserted claims under false advertising and other legal theories based on a marketing statement on the Company’s EZ Seed grass seed product from 2009 to 2012. The plaintiffs sought, on behalf of themselves and purported class members, various forms of monetary and non-monetary relief, including statutory damages that they contend could amount to hundreds of millions of dollars. The Company defended the action vigorously, and disputed the plaintiffs’ claims and theories, including the recoverability of statutory damages. In 2017, the Court eliminated certain claims, narrowed the case in certain respects, and permitted the case to continue proceeding as a class action. On August 7, 2017, the Court requested briefs on the Company’s request for interlocutory review of issues relating to the recoverability of statutory damages in a class action by the United States Court of Appeals for the Second Circuit and, on August 31, 2017, approved that request. On January 8, 2018, however, the Second Circuit denied the interlocutory appeal request. The parties engaged in mediation on April 9, 2018 and agreed in principle to a preliminary settlement of the outstanding claims on April 10, 2018. The preliminary settlement required the Company to pay certain attorneys’ and administrative fees and provide certain payments to the class members. The preliminary settlement was approved by the court on December 19, 2018. This case is now settled and the Company made final payment of the claims made by class members during the three months ended March 30, 2019. At March 30, 2019, March 31, 2018 and September 30, 2018, $0.1 million, $10.2 million, and $11.7 million, respectively, was accrued for a probable loss related to this matter in the “Other current liabilities” line in the Condensed Consolidated Balance Sheets. During the three and six months ended March 30, 2019, the Company recognized favorable adjustments of $0.9 million and $0.4 million, respectively, related to this matter in the “Impairment, restructuring and other” line in the Condensed Consolidated Statements of Operations as a result of the final payment of the claims made by class members.
The Company is involved in other lawsuits and claims which arise in the normal course of business. These claims individually and in the aggregate are not expected to result in a material effect on the Company’s financial condition, results of operations or cash flows.
NOTE 13. DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
The Company is exposed to market risks, such as changes in interest rates, currency exchange rates and commodity prices. To manage a portion of the volatility related to these exposures, the Company enters into various financial transactions. The utilization of these financial transactions is governed by policies covering acceptable counterparty exposure, instrument types and other hedging practices. The Company does not hold or issue derivative financial instruments for speculative trading purposes.
Exchange Rate Risk Management
The Company uses currency forward contracts to manage the exchange rate risk associated with intercompany loans and certain other balances denominated in foreign currencies. At March 30, 2019, the notional amount of outstanding currency forward contracts was $118.3 million, with a fair value of $1.5 million. At March 31, 2018, the notional amount of outstanding currency forward contracts was $252.9 million, with a fair value of $(0.7) million. At September 30, 2018, the notional amount of outstanding currency forward contracts was $117.2 million, with a fair value of $(0.6) million. The fair value of currency forward contracts is determined using forward rates in commonly quoted intervals for the full term of the contracts. Contracts outstanding at March 30, 2019 will mature over the next fiscal quarter.
Interest Rate Risk Management
The Company enters into interest rate swap agreements as a means to hedge its variable interest rate risk on debt instruments. Net amounts to be received or paid under the swap agreements are reflected as adjustments to interest expense. Since the interest rate swap agreements have been designated as hedging instruments, unrealized gains or losses resulting from adjusting these swaps to fair value are recorded as elements of AOCI within the Condensed Consolidated Balance Sheets. The fair value of the swap agreements is determined based on the present value of the estimated future net cash flows using implied rates in the applicable yield curve as of the valuation date.
The Company has outstanding interest rate swap agreements with major financial institutions that effectively convert a portion of the Company’s variable-rate debt to a fixed rate. The swap agreements had a maximum total U.S. dollar equivalent notional

25


amount of $1,300.0 million at March 30, 2019, $1,300.0 million at March 31, 2018 and $800.0 million at September 30, 2018. Refer to “NOTE 9. DEBT” for the terms of the swap agreements outstanding at March 30, 2019. Included in the AOCI balance at March 30, 2019 was a loss of $0.9 million related to interest rate swap agreements that is expected to be reclassified to earnings during the next twelve months, consistent with the timing of the underlying hedged transactions.
Commodity Price Risk Management
The Company enters into hedging arrangements designed to fix the price of a portion of its projected future urea requirements. The contracts are designated as hedges of the Company’s exposure to future cash flow fluctuations associated with the cost of urea. The objective of the hedges is to mitigate the earnings and cash flow volatility attributable to the risk of changing prices. Since the contracts have been designated as hedging instruments, unrealized gains or losses resulting from adjusting these contracts to fair value are recorded as elements of AOCI within the Condensed Consolidated Balance Sheets. Realized gains or losses remain as a component of AOCI until the related inventory is sold. Upon sale of the underlying inventory, the gain or loss is reclassified to cost of sales. Included in the AOCI balance at March 30, 2019 was a loss of $0.2 million related to urea derivatives that is expected to be reclassified to earnings during the next twelve months, consistent with the timing of the underlying hedged transactions.
The Company also uses derivatives to partially mitigate the effect of fluctuating diesel and resin costs on operating results. These financial instruments are carried at fair value within the Condensed Consolidated Balance Sheets. Changes in the fair value of derivative contracts that qualify for hedge accounting are recorded in AOCI. The effective portion of the change in fair value remains as a component of AOCI until the related commodity is consumed, at which time the accumulated gain or loss on the derivative contract is reclassified to cost of sales. Changes in the fair value of derivatives that do not qualify for hedge accounting are recorded as an element of cost of sales. At March 30, 2019, there were no amounts included within AOCI.
The Company had the following outstanding commodity contracts that were entered into to hedge forecasted purchases:
COMMODITY
 
MARCH 30,
2019
 
MARCH 31,
2018
 
SEPTEMBER 30,
2018
Urea
 
33,000 tons
 
42,000 tons

 
88,000 tons

Resin
 
6,100,000 pounds
 

 

Diesel
 
4,452,000 gallons
 
3,360,000 gallons

 
5,460,000 gallons

Heating Oil
 
756,000 gallons
 
1,092,000 gallons

 
1,218,000 gallons

Fair Values of Derivative Instruments
The fair values of the Company’s derivative instruments were as follows:
 
 
 
 
ASSETS / (LIABILITIES)
DERIVATIVES DESIGNATED AS  HEDGING INSTRUMENTS
 
BALANCE SHEET LOCATION
 
MARCH 30,
2019
 
MARCH 31,
2018
 
SEPTEMBER 30,
2018
 
 
 
 
(In millions)
Interest rate swap agreements
 
Prepaid and other current assets
 
$
0.9

 
$
1.5

 
$
2.0

 
 
Other assets
 
0.1

 
1.9

 
1.8

 
 
Other current liabilities
 
(1.9
)
 

 

 
 
Other liabilities
 
(4.4
)
 

 

Commodity hedging instruments
 
Prepaid and other current assets
 

 

 
6.1

 
 
Other current liabilities
 
(0.8
)
 
(0.5
)
 

Total derivatives designated as hedging instruments
 
$
(6.1
)
 
$
2.9

 
$
9.9

 
 
 
 
 
 
 
 
 
DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS
 
BALANCE SHEET LOCATION
 
 
 
 
 
 
Currency forward contracts
 
Prepaid and other current assets
 
$
1.5

 
$
0.3

 
$
0.9

 
 
Other current liabilities
 

 
(1.0
)
 
(1.5
)
Commodity hedging instruments
 
Prepaid and other current assets
 

 
1.1

 
1.7

 
 
Other current liabilities
 
(0.7
)
 

 

Total derivatives not designated as hedging instruments
 
0.8

 
0.4

 
1.1

Total derivatives
 
$
(5.3
)
 
$
3.3

 
$
11.0



26


The effect of derivative instruments on AOCI and the Condensed Consolidated Statements of Operations was as follows: 
DERIVATIVES IN CASH FLOW HEDGING RELATIONSHIPS
 
AMOUNT OF GAIN / (LOSS) RECOGNIZED IN AOCI
 
THREE MONTHS ENDED
 
SIX MONTHS ENDED
 
MARCH 30,
2019
 
MARCH 31,
2018
 
MARCH 30,
2019
 
MARCH 31,
2018
 
 
(In millions)
Interest rate swap agreements
 
$
(2.2
)
 
$
2.1

 
$
(6.8
)
 
$
2.5

Commodity hedging instruments
 
(0.2
)
 
(0.1
)
 
(3.5
)
 
0.3

Total
 
$
(2.4
)
 
$
2.0

 
$
(10.3
)
 
$
2.8


DERIVATIVES IN CASH FLOW HEDGING RELATIONSHIPS
 
RECLASSIFIED FROM AOCI INTO
STATEMENT OF OPERATIONS
 
AMOUNT OF GAIN / (LOSS)
THREE MONTHS ENDED
 
SIX MONTHS ENDED
MARCH 30,
2019
 
MARCH 31,
2018
 
MARCH 30,
2019
 
MARCH 31,
2018
 
 
 
 
(In millions)
Interest rate swap agreements
 
Interest expense
 
$
0.2

 
$
0.1

 
$
0.1

 
$
0.2

Commodity hedging instruments
 
Cost of sales
 
1.7

 
1.0

 
1.9

 
1.0

Total
 
$
1.9

 
$
1.1

 
$
2.0

 
$
1.2


DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS
 
RECOGNIZED IN
STATEMENT OF OPERATIONS
 
AMOUNT OF GAIN / (LOSS)
THREE MONTHS ENDED
 
SIX MONTHS ENDED
MARCH 30,
2019
 
MARCH 31,
2018
 
MARCH 30,
2019
 
MARCH 31,
2018
 
 
 
 
(In millions)
Currency forward contracts
 
Other income / expense, net
 
$
(0.2
)
 
$
(2.6
)
 
$
3.3

 
$
(5.2
)
Commodity hedging instruments
 
Cost of sales
 
1.5

 
0.2

 
(2.2
)
 
1.5

Total
 
$
1.3

 
$
(2.4
)
 
$
1.1

 
$
(3.7
)
NOTE 14. FAIR VALUE MEASUREMENTS
Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or the most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. A three-level fair value hierarchy prioritizes the inputs used to measure fair value. The hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows:
Level 1 — Quoted prices in active markets for identical assets or liabilities.
Level 2 — Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.
Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. This includes pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.
The following describes the valuation methodologies used for financial assets and liabilities measured at fair value on a recurring basis, as well as the general classification within the valuation hierarchy.
Cash Equivalents
Cash equivalents consist of highly liquid financial instruments with original maturities of three months or less. The carrying value of these cash equivalents approximates fair value due to their short-term maturities.

27


Derivatives
Derivatives consist of currency, interest rate and commodity derivative instruments. Currency forward contracts are valued using observable forward rates in commonly quoted intervals for the full term of the contracts. Interest rate swap agreements are valued based on the present value of the estimated future net cash flows using implied rates in the applicable yield curve as of the valuation date. Commodity contracts are measured using observable commodity exchange prices in active markets.
These derivative instruments are classified within Level 2 of the valuation hierarchy and are included within other assets and other liabilities in the Company’s Condensed Consolidated Balance Sheets, except for derivative instruments expected to be settled within the next 12 months, which are included within prepaid and other current assets and other current liabilities.
Other
Other assets include investment securities in non-qualified retirement plan assets and the Company’s option to increase its economic interest in Bonnie Plants, Inc. (the “Bonnie Option”). Other liabilities include the contingent consideration related to the acquisition of Sunlight Supply. Investment securities in non-qualified retirement plan assets are valued using observable market prices in active markets and are classified within Level 1 of the valuation hierarchy. The fair value of the Bonnie Option is determined using a simulation approach, whereby the total value of the loan receivable and optional exchange for additional equity was estimated considering a distribution of possible future cash flows discounted to present value using an appropriate discount rate, and is classified in Level 3 of the fair value hierarchy.
The following table presents the Company’s financial assets and liabilities measured at fair value on a recurring basis at March 30, 2019: 
 
Quoted Prices in Active
Markets for Identical Assets
(Level 1)
 
Significant Other
Observable Inputs
(Level 2)
 
Unobservable
Inputs
(Level 3)
 
Total
 
(In millions)
Assets
 
 
 
 
 
 
 
Cash equivalents
$
1.2

 
$

 
$

 
$
1.2

Derivatives
 
 
 
 
 
 
 
Interest rate swap agreements

 
1.0

 

 
1.0

Currency forward contracts

 
1.5

 

 
1.5

Other
20.9

 

 
13.0

 
33.9

Total
$
22.1

 
$
2.5

 
$
13.0

 
$
37.6

Liabilities
 
 
 
 
 
 
 
Derivatives
 
 
 
 
 
 
 
Interest rate swap agreements
$

 
$
(6.3
)
 
$

 
$
(6.3
)
Commodity hedging instruments

 
(1.5
)
 

 
(1.5
)
Other

 

 
(0.9
)
 
(0.9
)
Total
$

 
$
(7.8
)
 
$
(0.9
)
 
$
(8.7
)

28


The following table presents the Company’s financial assets and liabilities measured at fair value on a recurring basis at March 31, 2018: 
 
Quoted Prices in Active
Markets for Identical Assets
(Level 1)
 
Significant Other
Observable Inputs
(Level 2)
 
Unobservable
Inputs
(Level 3)
 
Total
 
(In millions)
Assets
 
 
 
 
 
 
 
Cash equivalents
$
0.9

 
$

 
$

 
$
0.9

Derivatives
 
 
 
 
 
 
 
Interest rate swap agreements